Noninvasive determination of liver collagen content in chronic hepatitis. Multivariate regression modeling with blood chemical parameters as variables

Journal of Gastroenterology

Volumn 32, Issue 3, 1997, Pages 355-360

  Takamatsu, Seigo ^a   Nakabayashi, Hitomi ^a   Okamoto, Yasuyuki ^a   Nakano, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Blood biochemical parameters; Liver collagen content; Multivariate regression analysis

Indexed keywords

COLLAGEN; COLLAGEN TYPE 3; COLLAGEN TYPE 4; HYALURONIC ACID; PROCOLLAGEN;

ADULT; ARTICLE; BLOOD CHEMISTRY; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE ANALYSIS; LABORATORY TEST; LIVER; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 0030905964     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02934493     Document Type: Article

References (40)

1. Melkko J, Niemi S, Risteli L, et al. Radioimmunoassay of carboxyterminal propeptide of type I procollagen. Clin Chem 1990;36:1328-1332.
2. Hartman DJ, Trinchet JC, Ricard-Blum S, et al. Radioimmunoassay of type I collagen that mainly detects degradation product in serum: Application to patients with liver disease. Clin Chem 1990;36:421-426.
3. Risteli J, Niemi S, Trivedi P, et al. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 1988;34:715-718.
4. Schuppan D, Besser M, Schwarting R, et al. Radioimmunoassay for the carboxy-terminal cross-linking domain of type IV (basement membrane) procollagen in body fluids. J Clin Invest 1986;78:241-248.
5. Hayasaka A, Schuppan D, Ohnishi K, et al. Serum concentration of carboxyterminal cross-linking domain of type IV (NC-1) and the aminoterminal propeptide of procollagen type in (P III P) in chronic liver disease. J Hepatol 1990;10:17-22.
6. Kropf J, Gressner AM, Negwer A. Efficacy of serum laminin measurement for diagnosis of fibrotic diseases. Clin Chem 1990;34:2026-2030.
7. Misaki M, Shima T, Yano Y, et al. Basement-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease. Clin Chem 1990;36:522-524.
8. Robert P, Champigneulle B, Kreher I, et al. Evaluation of fibrosis in the Disse space in non-cirrhotic alcohol liver disease. Alcoholism Clin Exp Res 1989;13:176-180.
9. Niemelae O, Risteli J, Blake JE, et al. Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Gastroenterology 1990;98:1612-1619.
10. Nakano H, Yamamoto Y, Ohnishi S, et al. Serum monoamine oxidase assayed with a synthetic bebzylamine derivative as substrate. Its clinical significance with special reference to hepatic fibrosis. Clin Chim Acta 1978;88:315-319.
11. Kuutti-Savolainen ER, Risteli J, Miettinen TA, et al. Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease. 1. Prolylhydroxlase. Eur J Clin Chem 1979;9:89-95.
12. Kuutti-Savolainen ER, Anttinen H, Miettinen TA, et al. Collagen biosynthesis enzyms in serum and hepatic tissue in liver disease. 2. Galactosyl hydroxylysyl glucosyltransferase. Eur J Clin Invest 1979;9:97-101.
13. Siegel RC, Chen KH, Greenspan JS, et al. Biochemical and immunochemical study of lysyl oxidase in experimental hepatic fibrosis in the rat. Proc Natl Acad Sci USA 1978;75:2945-2949.
14. Engstöem-Laurent A, Lööf L, Nyberg A, et al. Increased serum levels of hyaluronate in liver disease. Hepatology 1985;5:638-642.
15. Nyberg A, Engstöem-Laurent A, Lööf L. Serum hyluronate in primary biliary cirrhosis. A biochemical marker for progressive liver damage. Hepatology 1988;8:142-146.
16. León AL-D, Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 1985;33:737-743.
17. Jimenez W, Parés A, Caballería J, et al. Measurement of fibrosis in needle liver biopsy: Evaluation of a colorimetric method. Hepatology 1985;5:815-818.
18. Nakabayashi H, Takamatsu S, Nakano H. A simple estimation of liver collagen content by the computed color image analyzer using Sirius red stained section (in Japanese with English abstract). Acta Hepat Jap 1993;34:212-218.
19. Rohde H, Vargas L, Kalbfleisch H, et al. Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur J Clin Invest 1979;9:451-459.
20. Yamada S, Suou T, Kawasaki H, et al. Clinical significance of serum 7S collagen levels in various liver diseases. Clin Biochem 1992;25:467-470.
21. Obata K, Iwata K, Ichida T, et al. One-step sandwich enzyme immunoassay for human type IV collagen using monoclonal antibodies. Clin Chim Acta 1989;181:293-304.
22. Sakamoto Y, Ishiguro M, Kitagawa G, Johoryotokeigaku. Tokyo: Kyoritsu Shuppan, 1983; 42-64.
23. Koizumi T, Mitsutani N, Kagawa H, et al. N-acetyl-β-glucosaminidase activity in hepatic fibrosis. Lab Invest 1964; 13:752-756.
24. Frei A, Zimmerman A, Weigand K. The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease. Hepatology 1984;4:830-834.
25. Galambos MR, Collins DC, Galambos JT. A radioimmunoassay procedure for type III procollagen: Its use in the detection of hepatic fibrosis. Hepatology 1985;5:38-42.
26. Nakano H, Kawasaki T, Miyamura M, et al. Serum levels of N-terminal type III procollagen peptide in normal subjects and comparison to hepatic fibrosis. Acta Hepatol Jap 1983;24:1230-1234.
27. Tsutsumi M, Urashima S, Matsuda Y, et al. Change in type IV collagen content in livers of patients with alcoholic liver disease. Hepatology 1993;17:820-827.
28. Ueno T, Inuzuka S, Torimura T, et al. Significance of serum type-IV collagen levels in various liver diseases. Measurement with a one-step sandwich enzyme immunoassay using monoclonal antibodies with specificity for pepsin-solubilized type-IV collagen. Scand J Gastroenterol 1992;27:513-520.
29. Yamada S, Kishimoto Y, Suou T, et al. Heterogeneity of antigens related to 7S domain of type IV collagen in serum; Application to patients with chronic liver disease. Clin Chim Acta 1992;212:73-78.
30. Timple R, Glanvill RW. The aminopeptidase of collagen. Clin Orthop 1981;158:224-242.
31. McCullough AJ, Stanssen WN, Wiesner RH, et al. Serum type III procollagen peptide concentrations in severe chronic active hepatitis: Relationship to cirrhosis and disease activity. Hepatology 1987;7:49-54.
32. Surrenti C, Casini A, Milani S, et al. Is determination of serum N-terminal procollagen type III peptide (sP III P) a marker of hepatic fibrosis? Dig Dis Sci 1987;32:705-709.
33. Annoni G, Colombo M, Cantaluppi MC, et al. Serum type III procollagen peptide and laminin (lam-P1) detect alcoholic hepatitis in chronic alcohol abusers. Hepatology 1989;9:693-697.
34. Schaffner F, Popper H. Capillarization of hepatic sinusoids in man. Gastroenterology 1963;44:239-242.
35. Fukutomi T, Sakamoto S, Isobe H, et al. Clinical significance of serum levels of the 7S domain of type IV collagen in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 1992;7:596-601.
36. Matsumoto E, Muragaki Y, Ooshima A. Increased amount of serum type IV collagen peptide in human liver fibrosis as determined by enzyme immunoassay with monoclonal antibodies. Acta Pathol Jap 1989;39:217-223.
37. Eriksson S, Franser JRE, Laurent TC, et al. Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res 1983;144:223-228.
38. Smedsrod B, Pertoft H, Eriksson S, et al. Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J 1984;223:617-626.
39. Ueno T, Inuzuka S, Torimura T, et al. Serum hyaluronate reflects hepatic sinusoidal capillarization. Gastroenterology 1993;105: 475-481.
40. Deaciuc IV, Bagby GJ, Lang CH, et al. Hyaluronic acid uptake by the isolated, perfused rat liver: An index of hepatic sinusoidal endothelial cell function. Hepatology 1993;17:266-272.